The launch of ADIPOA2, which includes Dutch partner, has created interest in news outlets in the Netherlands. See examples of coverage at http://www.nu.nl/gezondheid/4065072/ziekenhuizen-testen-behandeling-artrose-met-stamcellen.html https://fysioforum.nl/2015/06/09/onderzoek-naar-stamcelbehandeling-voor-knieartrose/ http://www.omroepgelderland.nl/nieuws/2094435/Radboudumc-partner-in-vernieuwend-reuma-onderzoek ADIPOA2 has also been publicised by the Dutch Arthritis Foundation, Reumafonds http://www.reumafonds.nl/actueel/nieuwsoverzicht/stamcelbehandeling-voor-knieartrose-onderzocht RUMC press release: Persbericht Nijmegen, 09 juni 2015 Europese subsidie van bijna 6 miljoen euro voor innovatieve therapie […]
This author has yet to write their bio.Meanwhile lets just say that we are proud aoife contributed a whooping 25 entries.
Entries by aoife
Jessica Hayes, a postdoctoral researcher from NUI, Galway, who has been involved in ADIPOA2 since proposal stage, is among a group of Irish researchers who have been recognised by the Irish Research Council for the excellence of their research. The six exceptional early stage career researchers under the age of 35 will, later this month, […]
Our sister project REDDSTAR and Leiden University Medical Center are co-organizing EU MSC2 2015, a meeting in Leiden, NL on September 7th and 8th to bring together nine EU-funded, mesenchymal stromal cell-focussed consortia. Projects include: REDDSTAR, REACH, RETHRIM, Stellar, MERLIN, Nephstrom, SCIENCE, VISICORT and Adipoa-2. This two day, interactive meeting will be held at the […]
A large-scale clinical trial using adult stem cells to treat knee osteoarthritis is expected to be underway across Europe by the end of 2015. Almost €6 million has been granted to the project ‘ADIPOA-2’ by the EU’s Horizon 2020 research funding programme. The project will include 18 partners from Ireland, France, the UK, Germany, Italy […]
The first meetings of the ADIPOA-2 consortium have taken place, as work begins on this exciting new European project, which is developing a novel stem cell therapy for osteoarthritis. The ADIPOA-2 clinical team, which includes clinicians from ten centres in France, Germany, Ireland, Italy, and the Netherlands, met in Paris on December 16, to agree […]
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643809. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.